The earnings call presented a mixed performance with stable net sales and a significant increase in order intake, especially in the medical division. However, profitability was impacted by the absence of previous one-off effects and negative impacts from currency fluctuations and tariffs. While the company remains optimistic about future growth and maintains its annual guidance, the challenges in profitability and external headwinds cannot be overlooked.

Company Guidance

In the Q2 2025 earnings call, the company reported stable net sales of approximately EUR 1.5 billion, with a slight nominal decline compared to the previous year, although net sales increased slightly when adjusted for currency effects. The medical division drove growth, contrasting with the prior year's performance led by the safety division. Earnings before interest and taxes (EBIT) were just over EUR 20 million, falling short of the previous year's figures due to the absence of EUR 20 million in one-off effects from divestments in 2024. Order intake saw significant growth, reaching EUR 1.7 billion, marking the highest since the first half of 2020, despite challenges from U.S. customs policies. Operating cash flow returned to positive territory at EUR 18 million, up from a deficit in the prior year. The company maintained a 44.8% gross margin, with a 1.8% net sales increase in Q2, and confirmed its annual guidance for net sales growth between 1% and 5%, and an EBIT margin between 3.5% and 6.5%. The company plans to consolidate operations in its Neonatal care business, anticipating efficiency improvements and cost reductions by 2026.

Solid Business Performance and Order Intake

Achieved stable net sales around EUR 1.5 billion, with growth driven by the medical division. Order intake increased significantly to EUR 1.7 billion, marking the highest first-half order intake since 2020.

Improvement in Operating Cash Flow

Operating cash flow improved to EUR 18 million from a negative EUR 5 million in the prior year period, driven by effective working capital management.

Share Price Increase and TecDAX Inclusion

Common shares rose by more than 33%, and preferred shares by over 40%. Preferred shares listed in the SDAX were also included in the TecDAX.

Strong Order Growth in Medical Division

Order intake in the medical division grew by almost 15% to over EUR 1 billion, driven by strong demand for ventilators and other medical equipment.

Draegerwerk AG & Co. KGaA (DE:DRW8) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

DE:DRW8 Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	- / -	0.77	―	―	―
Jul 29, 2025	2025 (Q2)	0.61 / 0.61	1.42	-57.04% (-0.81)	―	―
Apr 30, 2025	2025 (Q1)	- / -	0.378	―	―	―
Mar 31, 2025	2024 (Q4)	6.28 / -0.10	0.378	-126.46% (-0.48)	―	―
Oct 29, 2024	2024 (Q3)	- / 0.77	0.939	-18.00% (-0.17)	―	―
Jul 25, 2024	2024 (Q2)	- / 1.42	0.571	148.69% (+0.85)	―	―
Apr 25, 2024	2024 (Q1)	- / 0.38	0.908	-58.37% (-0.53)	―	―
Mar 07, 2024	2023 (Q4)	- / 3.47	2.577	34.58% (+0.89)	―	―
Nov 02, 2023	2023 (Q3)	- / 0.94	-1.5	162.60% (+2.44)	―	―
Jul 27, 2023	2023 (Q2)	- / 0.57	-2.714	121.04% (+3.29)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

DE:DRW8 Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 29, 2025	€56.80	€58.40	+2.82%
Apr 30, 2025	€47.02	€47.51	+1.02%
Mar 31, 2025	€50.97	€50.20	-1.51%
Oct 29, 2024	€41.26	€40.01	-3.03%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Draegerwerk AG & Co. KGaA (DE:DRW8) report earnings?

Draegerwerk AG & Co. KGaA (DE:DRW8) is schdueled to report earning on Oct 29, 2025, TBA (Confirmed).

What is Draegerwerk AG & Co. KGaA (DE:DRW8) earnings time?

Draegerwerk AG & Co. KGaA (DE:DRW8) earnings time is at Oct 29, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is the P/E ratio of Draegerwerk AG & Co. KGaA stock?

The P/E ratio of Draegerwerk AG & Co. KGaA is N/A.

What is DE:DRW8 EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing